We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$110B
AUM Growth
+$13.5B
Cap. Flow
+$623M
Cap. Flow %
0.57%
Top 10 Hldgs %
19.69%
Holding
4,289
New
439
Increased
1,583
Reduced
1,749
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 11.42%
2 Financials 9.4%
3 Healthcare 9.26%
4 Consumer Discretionary 6.46%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
3551
Voyager Therapeutics
VYGR
$183M
$255K ﹤0.01%
13,276
+274
+2% +$3.57K
ASXC
3552
DELISTED
Asensus Surgical, Inc.
ASXC
$255K ﹤0.01%
8,259
+1,483
+22% +$49.7K
UCFC
3553
DELISTED
United Community Financial Corp
UCFC
$255K ﹤0.01%
27,218
-7,709
-22% -$72.9K
FKU icon
3554
First Trust United Kingdom AlphaDEX Fund
FKU
$38.7M
$254K ﹤0.01%
6,947
-18,872
-73% -$674K
NRK icon
3555
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$254K ﹤0.01%
19,973
BFYT
3556
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$254K ﹤0.01%
9,457
-3,765
-28% -$133K
MOBL
3557
DELISTED
MobileIron, Inc.
MOBL
$254K ﹤0.01%
46,417
+13,248
+40% +$65.3K
CYTK icon
3558
Cytokinetics
CYTK
$10.5B
$253K ﹤0.01%
31,378
+7,850
+33% +$57.7K
GSK icon
3559
GSK
GSK
$104B
$253K ﹤0.01%
4,845
-1,376
-22% -$68.8K
ACH
3560
Accendra Health
ACH
$237M
$253K ﹤0.01%
61,503
-12,945
-17% -$81.9K
NVMI
3561
Nova
NVMI
$12.4B
$252K ﹤0.01%
10,011
+395
+4% +$9.57K
TK icon
3562
Teekay
TK
$1.01B
$251K ﹤0.01%
64,249
+51,792
+416% +$196K
CONN
3563
DELISTED
Conn's Inc.
CONN
$251K ﹤0.01%
10,995
-12,922
-54% -$278K
EXPR
3564
DELISTED
Express, Inc.
EXPR
$251K ﹤0.01%
2,923
-2,462
-46% -$248K
ATNX
3565
DELISTED
Athenex, Inc. Common Stock
ATNX
$251K ﹤0.01%
1,026
-116
-10% -$28.3K
GTHX
3566
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$250K ﹤0.01%
15,075
+3,594
+31% +$68.2K
CZR
3567
CALL
DELISTED
Caesars Entertainment Corporation
CZR
$249K ﹤0.01%
28,700
AMAL icon
3568
Amalgamated Financial
AMAL
$1.48B
$247K ﹤0.01%
15,733
-6,460
-29% -$116K
ARLO icon
3569
Arlo Technologies
ARLO
$1.6B
$247K ﹤0.01%
59,928
+29,103
+94% +$161K
CIA icon
3570
Citizens
CIA
$239M
$247K ﹤0.01%
37,023
+8,947
+32% +$63.8K
FPH icon
3571
Five Point Holdings
FPH
$373M
$247K ﹤0.01%
34,198
+13,115
+62% +$98.7K
BSTC
3572
DELISTED
BioSpecifics Technologies Corp.
BSTC
$247K ﹤0.01%
+3,957
New +$262K
LTM
3573
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$247K ﹤0.01%
23,392
-47,443
-67% -$545K
ATRS
3574
DELISTED
Antares Pharma, Inc.
ATRS
$246K ﹤0.01%
80,720
+6,684
+9% +$21.7K
BSM icon
3575
Black Stone Minerals
BSM
$3.18B
$244K ﹤0.01%
13,806
-1,217
-8% -$20.9K

Similar funds

Credit Suisse's Q1 2019 Portfolio in Review

As of Q1 2019, Credit Suisse held 4,289 positions worth $110B, up 14% from $96.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse's Q1 2019 filing shows 439 new, 1,583 increased, 1,749 reduced and 327 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 4,000,000 shares worth $232M. The largest sale was iShares MSCI Brazil ETF, an estimated $574M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Credit Suisse's largest Q1 2019 buy was iShares Core MSCI Total International Stock ETF: 4,000,000 shares worth $232M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $1.78B increase.
  • Credit Suisse's biggest Q1 2019 reduction was iShares MSCI Brazil ETF, cutting an estimated $574M.
  • Credit Suisse fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $186M.
  • Credit Suisse's ten largest holdings make up 20% of its $110B portfolio in Q1 2019.
  • Credit Suisse opened 439 new positions and closed 327 in Q1 2019.
  • Credit Suisse's portfolio value rose 14% quarter-over-quarter to $110B.

Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.